Sigrid Balser

Development of a new G-CSF product based on biosimilarity assessment

Pere Gascón, Uwe Fuhr, F. Sörgel et al. · Annals of Oncology · 2009 · 90 citations · Full text

Bioanalysis, Biotechnology, Biostatistics +2

Population Modeling of Filgrastim PK‐PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

Wojciech Krzyżański, Paweł Wiczling, Etienne Pigeolet et al. · The Journal of Clinical Pharmacology · 2010 · 49 citations

Population Pharmacokinetic and Pharmacodynamic Model‐Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575

Xiaoyu Yan, Philip J. Lowe, Martin Fink et al. · The Journal of Clinical Pharmacology · 2011 · 38 citations · Full text

Population Pharmacokinetic, Comparability Assessment, Pharmacokinetic Modeling +14

Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial

Stephen B. Hanauer, Bernd Liedert, Sigrid Balser et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 38 citations

Advanced Crohn, Gastroenterology, Clinical Trials +6

Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations

Paweł Wiczling, Philip J. Lowe, Etienne Pigeolet et al. · Clinical Pharmacokinetics · 2009 · 27 citations

Subcutaneous Administrations, Pharmacokinetic Modeling, Pharmacodynamics +8